Despite its known oncogenic potential, the role of BRAF in MPNST pathogenesis remains largely unexplored, and there are currently no preclinical models specifically designed to study BRAF-driven MPNSTs. Here, BRAF is linked to malignant peripheral nerve sheath tumor.